|
|
|
|
H1N1 Consulting
Paradigm
Shift
Viral
Evolution
Intervention
Monitoring
Vaccine
Screening
Vaccine
Development
Expression
Profiling
Drug
Discovery
Custom
Therapies
Patents
|
|
|
Audio: Mar23 May
4 Jul13 Jul29 Aug20
Commentary
Tamiflu
Resistance in Vietnam Increases Concerns
Recombinomics Commentary 13:11
August 25, 2009
Experience over 2-3 times the number of
days of treatment compared with regular time and had thought at death,
two cases can cum A/H1N1 have been heavily doctor Pham Ngoc Thach
hospital Savior success.
Previously, patients
underwent 12 CTH was immediately treated influenza A/H1N1 ineffective.
The VMQ patients still positive for influenza A/H1N1 to 22 days after
treatment
However, through the use
Ralenza to treatment instead of Tamiflu (flu Ralenza only treatment for
severe cases). Latest test results immediately 24/8 that the two
patients were negative to H1N1 virus and will discharge in a few days.
The above translation suggests there are multiple cases of Tamiflu
resistant H1N1 in Vietnam. Patients treated with Tamiflu failed
to respond, even when treated early, but treatment with Relenza
produced improvement and elimination of H1N1.
These data follow reports from adjacent Thailand
on resistance there, and suggest that resistance is becoming
increasingly widespread. The first confirmed case of resistance was in Singapore,
where the patient (in May) quickly
developed resistance, suggesting H274Y was circulating as a minor
population which was not detected in samples collected prior to
treatment, but was found in the absence of wild type a few days after
the start of treatment.
Similarly, the four confirmed cases in the United States fall into two clusters
of two (in immune-compromised patients
in Seattle
and summer campers
in North Carolina), which again suggest resistance is circulating as a
minor population which leads to rapid appearance of resistance.
Clusters of cases in Texas along the Mexican border have been reported
and denied.
Moreover, prophylactic and treatment use of Relenza is appearing at
increased frequency in containment recommendations, further supporting
the evidence indicating Tamiflu resistance is worldwide and increasing.
Media
Links
Recombinomics
Presentations
Recombinomics
Publications
Recombinomics
Paper
at Nature Precedings
|